Quarterly report pursuant to Section 13 or 15(d)

Marketable securities

v3.20.1
Marketable securities
3 Months Ended
Mar. 31, 2020
Marketable securities  
Marketable securities

Note 7 — Marketable securities

As of March 31, 2020, the Company has the following investments in marketable securities (in thousands):

Gross

Gross

Aggregate

Remaining

Amortized

Unrealized

Unrealized

Estimated

    

Contractual Maturity

    

Cost

    

Gains

    

Losses

    

Fair Value

Cash equivalents:

 

  

 

  

 

  

 

  

 

  

Corporate debt securities

Less than 3 months

10,338

2

(3)

10,337

 

  

$

10,338

$

2

$

(3)

$

10,337

Available-for-sale debt securities:

 

  

 

  

 

  

 

  

 

  

Corporate debt securities

 

Less than 3 months

$

13,684

$

7

$

(17)

$

13,674

Corporate debt securities

3 months to 1 year

76,635

8

(455)

76,188

Treasury bills

3 months to 1 year

1,991

7

1,998

Corporate debt securities

1 year to 2 years

18,238

3

(101)

18,140

 

  

$

110,548

$

25

$

(573)

$

110,000

As of March 31, 2020 and December 31, 2019, the aggregate fair value of securities held by the Company in an unrealized loss position was $90.9 million and $2.0 million respectively, which consisted of 36 and 1 separate securities, respectively. No securities have been in an unrealized loss position for more than one year.

As of March 31, 2020, the securities in an unrealized loss position are not considered to be other than temporarily impaired because the impairments are not severe and have been for a short duration. The Company has considered potential impairments in light of COVID-19 and its impact on markets, and the Company has concluded that this impact is not other than temporary for the Company’s securities. The Company does not intend to sell the debt securities in an unrealized loss position and believes that it has the ability to hold the debt securities to maturity.